Schedule 13G ownership disclosure
NEWAMSTERDAM PHARMA COMPANY
Common Stock · CUSIP: N62509109
Event date: 2025-06-30
- Filing-level shares
- 8,387,725.00
- Percent of class
- 7.5%
- Capital World Investors
Shares: 8,387,725.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-25-000040
- Form type
- SCHEDULE 13G/A
- Filer
- Capital World Investors
- CIK
- CIK 1422849
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership